J Thomas Pento Selected Research

Fibroblast Growth Factor 7

1/2015	Oncolytic potential of a novel KGFR tyrosine kinase inhibitor using a KGFR-selective breast cancer xenograft model.
12/2010	Influence of novel KGFR tyrosine kinase inhibitors on KGF-mediated proliferation of breast cancer.
8/2009	Influence of KGF on the progression of pancreatic cancer.
9/2008	SiRNA inhibition of ER-alpha expression reduces KGF-induced proliferation of breast cancer cells.
1/2008	Wilms' tumor 1 protein and focal adhesion kinase mediate keratinocyte growth factor signaling in breast cancer cells.
11/2006	A Comparison of KGF Receptor Expression in Various Types of Human Cancer.
3/2006	Enhanced motility of KGF-transfected breast cancer cells.
7/2004	Keratinocyte Growth Factor-Mediated Pattern of Gene Expression in Breast Cancer Cells.
1/2004	KGF-induced motility of breast cancer cells is dependent on Grb2 and Erk1,2.
11/2003	Antisense KGFR oligonucleotide inhibition of KGF-induced motility in breast cancer cells.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

J Thomas Pento Research Topics

Disease

17	Breast Neoplasms (Breast Cancer) 01/2015 - 01/2002
11	Neoplasms (Cancer) 12/2010 - 01/2002
2	Neoplasm Metastasis (Metastasis) 01/2008 - 01/2002
1	Polyps 03/2014
1	Intestinal Polyps 03/2014
1	Adenomatous Polyposis Coli (Familial Adenomatous Polyposis) 03/2014
1	Colorectal Neoplasms (Colorectal Cancer) 03/2014
1	Pancreatic Neoplasms (Pancreatic Cancer) 08/2009
1	Wilms Tumor (Wilm's Tumor) 01/2008
1	Prostatic Neoplasms (Prostate Cancer) 09/2007

Drug/Important Bio-Agent (IBA)

11	Fibroblast Growth Factor 7 FDA Link 01/2015 - 08/2002
7	Estrogen ReceptorsIBA 09/2008 - 01/2002
5	keratinocyte growth factor receptorIBA 01/2015 - 11/2003
5	Tyrosine Kinase InhibitorsIBA 01/2015 - 01/2004
5	Proteins (Proteins, Gene)FDA Link 01/2009 - 10/2003
4	Methionine (L-Methionine)FDA Link 01/2009 - 10/2003
4	L-methionine gamma-lyaseIBA 01/2009 - 10/2003
4	Urokinase-Type Plasminogen Activator (Urokinase)FDA Link 01/2009 - 10/2003
3	Complementary DNA (cDNA)IBA 01/2008 - 07/2004
3	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2007 - 01/2002
2	Antineoplastic Agents (Antineoplastics)IBA 12/2010 - 11/2007
2	EnzymesIBA 09/2007 - 10/2003
2	Estrogen Receptor Modulators (Antiestrogen)IBA 01/2007 - 01/2002
1	Biological ProductsIBA 12/2010
1	Estrogens (Estrogen)FDA Link 09/2008
1	Small Interfering RNA (siRNA)IBA 09/2008
1	Focal Adhesion Protein-Tyrosine KinasesIBA 01/2008
1	Epidermal Growth Factor (EGF)IBA 01/2007
1	Biomarkers (Surrogate Marker)IBA 11/2006
1	RNA (Ribonucleic Acid)IBA 08/2004
1	ProhibitinsIBA 08/2004
1	3' Untranslated Regions (3' UTR)IBA 08/2004
1	Messenger RNA (mRNA)IBA 07/2004
1	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 01/2004
1	GenisteinIBA 01/2004
1	OligonucleotidesIBA 11/2003
1	Amino Acids FDA Link 10/2003
1	Cytotoxins (Cytolysins)IBA 10/2003
1	Conditioned Culture MediaIBA 08/2002
1	Transforming Growth Factor beta (TGF-beta)IBA 01/2002
1	CollagenIBA 01/2002
1	Collagenases (Collagenase)FDA Link 01/2002

Therapy/Procedure

1	Chemoprevention 11/2007